{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:54:00Z","timestamp":1781711640582,"version":"3.54.5"},"reference-count":24,"publisher":"Norwegian Medical Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.24.0476","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:15:51Z","timestamp":1740554151000},"source":"Crossref","is-referenced-by-count":0,"title":["X-linked hypophosphataemia"],"prefix":"10.4045","volume":"145","author":[{"given":"Qidi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cennet","family":"Akdeniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Heck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Britt","family":"Bj\u00f8rk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Rasmus","family":"Theisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Beate","family":"Eggesb\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tormod B.","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne E.","family":"Reseland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Kampen","family":"Pihlstr\u00f8m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Olav","family":"\u00c5svold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guri","family":"Grimnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-628X","authenticated-orcid":false,"given":"Marianne Aardal","family":"Grytaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silje Hjort","family":"Rafaelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-1035","authenticated-orcid":false,"given":"Per M.","family":"Thorsby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Lande","family":"Wekre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine E.","family":"Finnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref=1","unstructured":"Ariceta\u00a0G, Beck-Nielsen\u00a0SS, Boot\u00a0AM et al. The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data. Orphanet J Rare Dis 2023; 18: 304. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37752558&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs13023-023-02882-4"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Skrinar\u00a0A, Dvorak-Ewell\u00a0M, Evins\u00a0A et al. The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. J Endocr Soc 2019; 3: 1321\u201334. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31259293&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1210%2Fjs.2018-00365","DOI":"10.1210\/js.2018-00365"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Clinkenbeard\u00a0EL, White\u00a0KE. Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics. Bone 2017; 102: 31\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28159712&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.bone.2017.01.034","DOI":"10.1016\/j.bone.2017.01.034"},{"key":"ref=4","unstructured":"Orphanet. X-linked hypophosphatemia. https:\/\/www.orpha.net\/en\/disease\/detail\/89936 Lest 6.8.2024."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Brandi\u00a0ML, Ariceta\u00a0G, Beck-Nielsen\u00a0SS et al. Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description. Ther Adv Chronic Dis 2022; 13: 20406223221117471. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36082134&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F20406223221117471","DOI":"10.1177\/20406223221117471"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Rafaelsen\u00a0S, Johansson\u00a0S, R\u00e6der\u00a0H et al. Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. Eur J Endocrinol 2016; 174: 125\u201336. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26543054&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1530%2FEJE-15-0515","DOI":"10.1530\/EJE-15-0515"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Haffner\u00a0D, Emma\u00a0F, Eastwood\u00a0DM et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 2019; 15: 435\u201355. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31068690&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fs41581-019-0152-5","DOI":"10.1038\/s41581-019-0152-5"},{"key":"ref=8","unstructured":"Beck-Nielsen\u00a0SS, Mughal\u00a0Z, Haffner\u00a0D et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 2019; 14: 58. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30808384&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs13023-019-1014-8"},{"key":"ref=9","unstructured":"Laurent MR, Harvengt P, Mortier GR et al. X-Linked Hypophosphatemia. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83985\/ Lest 20.11.2024."},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Chaussain-Miller\u00a0C, Sinding\u00a0C, Septier\u00a0D et al. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 2007; 13: 482\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17714351&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1601-0825.2006.01326.x","DOI":"10.1111\/j.1601-0825.2006.01326.x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Beck-Nielsen\u00a0SS, Brusgaard\u00a0K, Rasmussen\u00a0LM et al. Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 2010; 87: 108\u201319. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20524110&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00223-010-9373-0","DOI":"10.1007\/s00223-010-9373-0"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Che\u00a0H, Roux\u00a0C, Etcheto\u00a0A et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 2016; 174: 325\u201333. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26783348&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1530%2FEJE-15-0661","DOI":"10.1530\/EJE-15-0661"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Connor\u00a0J, Olear\u00a0EA, Insogna\u00a0KL et al. Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease. J Clin Endocrinol Metab 2015; 100: 3625\u201332. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26176801&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1210%2FJC.2015-2199","DOI":"10.1210\/JC.2015-2199"},{"key":"ref=14","unstructured":"Yanes\u00a0MIL, Diaz-Curiel\u00a0M, Peris\u00a0P et al. Health-related quality of life of X-linked hypophosphatemia in Spain. Orphanet J Rare Dis 2022; 17: 298. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35906684&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1186%2Fs13023-022-02452-0"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Carpenter\u00a0TO, Imel\u00a0EA, Holm\u00a0IA et al. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 2011; 26: 1381\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21538511&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjbmr.340","DOI":"10.1002\/jbmr.340"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Linglart\u00a0A, Biosse-Duplan\u00a0M, Briot\u00a0K et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 2014; 3: R13\u201330. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24550322&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1530%2FEC-13-0103","DOI":"10.1530\/EC-13-0103"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Bacchetta\u00a0J, Sea\u00a0JL, Chun\u00a0RF et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 2013; 28: 46\u201355. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22886720&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjbmr.1740","DOI":"10.1002\/jbmr.1740"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Portale\u00a0AA, Ward\u00a0L, Dahir\u00a0K et al. Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study. J Bone Miner Res 2024; 39: 1493\u2013502. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39151033&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fjbmr%2Fzjae127","DOI":"10.1093\/jbmr\/zjae127"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Lecoq\u00a0AL, Chaumet-Riffaud\u00a0P, Blanchard\u00a0A et al. Hyperparathyroidism in Patients With X-Linked Hypophosphatemia. J Bone Miner Res 2020; 35: 1263\u201373. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32101626&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjbmr.3992","DOI":"10.1002\/jbmr.3992"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Insogna\u00a0KL, Briot\u00a0K, Imel\u00a0EA et al. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res 2018; 33: 1383\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29947083&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fjbmr.3475","DOI":"10.1002\/jbmr.3475"},{"key":"ref=21","unstructured":"European Medicines Agency\u2019s (EMA). New medicine for rare bone disease 2017. https:\/\/www.ema.europa.eu\/en\/news\/new-medicine-rare-bone-disease Lest 1.8.2024."},{"key":"ref=22","unstructured":"Nye metoder. Beslutningsforum for nye metoder. Innkalling og saksdokumenter. https:\/\/www.nyemetoder.no\/4af62e\/siteassets\/documents\/beslutninger\/beslutningsforum-13122021---offentlige-sakspapirer.pdf Lest 1.8.2024."},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Briot\u00a0K, Portale\u00a0AA, Brandi\u00a0ML et al. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension. RMD Open 2021; 7: e001714. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34548383&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Frmdopen-2021-001714","DOI":"10.1136\/rmdopen-2021-001714"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Bj\u00f8rk\u00a0MB, Bleka\u00a0\u00d8, Kvaal\u00a0SI et al. MRI segmentation of tooth tissue in age prediction of sub-adults - a new method for combining data from the 1st, 2nd, and 3rd molars. Int J Legal Med 2024; 138: 939\u201349. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38147158&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00414-023-03149-0","DOI":"10.1007\/s00414-023-03149-0"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["X-bundet hypofosfatemi"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:19:17Z","timestamp":1781709557000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2025\/02\/klinisk-oversikt\/x-bundet-hypofosfatemi"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.24.0476","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}